FFBC:NASDAQFirst Financial Bancorp. Analysis
Data as of 2026-04-02 - not real-time
$28.08
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
First Financial Bancorp (FFBC) trades around $28, comfortably above its 20‑day SMA but just below the 50‑day SMA, indicating a neutral short‑term trend. The MACD histogram is positive and the RSI sits in the mid‑50s, suggesting limited downside pressure while the recent earnings release is imminent, which could add volatility. Fundamentally, the stock appears undervalued – a DCF fair‑value estimate near $69 implies roughly a 14% upside, the PE ratio is well under the industry average, and the dividend yield of 3.5% with a modest 36% payout ratio signals sustainability.
Given the stable volume, low beta, and a solid balance sheet with ample cash relative to debt, the risk profile is moderate. Investors seeking both income and upside should consider the stock’s attractive valuation and growth‑oriented revenue expansion, while keeping an eye on the upcoming earnings and broader regional‑bank sentiment.
Given the stable volume, low beta, and a solid balance sheet with ample cash relative to debt, the risk profile is moderate. Investors seeking both income and upside should consider the stock’s attractive valuation and growth‑oriented revenue expansion, while keeping an eye on the upcoming earnings and broader regional‑bank sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical positioning near support and resistance
- Upcoming earnings announcement could trigger short‑term volatility
- Positive MACD histogram and moderate RSI
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF and industry PE
- Strong revenue growth and solid dividend yield
- Low beta and stable liquidity
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend with comfortable payout ratio
- Fundamental upside potential from valuation gap
- Steady cash position and manageable debt profile
Key Metrics & Analysis
Financial Health
Revenue Growth21.60%
Profit Margin29.88%
P/E Ratio10.6
ROE9.82%
ROA1.29%
P/B Ratio1.0
Op. Cash Flow$337.9M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI56.4
Support$26.06
Resistance$28.41
MA 20$27.22
MA 50$28.36
MA 200$25.95
MACDBullish
VolumeStable
Fear & Greed Index77.61
Valuation
Fair Value$69.37
Target Price$32.14
Upside/Downside14.47%
GradeUndervalued
TypeBlend
Dividend Yield3.53%
Risk Assessment
Beta0.75
Volatility25.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.